An Economic Analysis of Transjugular Intrahepatic Portosystemic Covered Stent Shunt for Variceal Bleeding and Refractory Ascites in a Spanish Setting

被引:1
|
作者
Banares, Rafael [1 ,2 ,3 ]
Albillos, Agustin [3 ,4 ]
Nakum, Mitesh [5 ]
Gea, Salvador [6 ]
Varghese, Angel [7 ]
Green, William [7 ]
机构
[1] Hosp Gen Univ Gregorio Maranon, Serv Med Aparato Digest, Inst Invest Sanitaria Gregorio Maranon, Madrid, Spain
[2] Univ Complutense Madrid, Madrid, Spain
[3] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Madrid, Spain
[4] Hosp Univ Ramon y Cajal, Dept Gastroenterol & Hepatol, Inst Ramon y Cajal Invest Sanitaria IRYCIS, Madrid, Spain
[5] WL Gore & Associates Ltd, Newark, NJ USA
[6] Gore & Asociados SL, Barcelona, Spain
[7] Univ York, York Hlth Econ Consortium Ltd, Enterprise House,Innovat Way, York YO10 5NQ, England
关键词
Variceal bleeding; Ascites; Cirrhosis; TIPSS; Endoscopic band ligation; Large volume paracentesis; Spain; Cost-utility; QALY; QUALITY-OF-LIFE; COST-EFFECTIVENESS; ESOPHAGEAL-VARICES; FREE SURVIVAL; TIPS; CIRRHOSIS; METAANALYSIS; PREVENTION;
D O I
10.1007/s12325-023-02517-x
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
IntroductionThe primary aim is to estimate the cost-effectiveness of transjugular intrahepatic portosystemic stent shunt (TIPSS) in two indications from a Spanish perspective. Firstly, as pre-emptive treatment for patients with acute variceal bleeding (indication 1) compared with endoscopic band ligation plus drug therapy. Secondly, to treat refractory ascites (indication 2) compared with large volume paracentesis.MethodsA two-state (alive and dead) Markov model was developed to capture the costs and health impact for the two indications over a 2-year time horizon with monthly cycles. In the alive state, patients could experience adverse event(s), associated with costs and disutility, such as recurrent variceal bleeding, ascites, and hepatic encephalopathy. Discount rates of 3% for utilities and costs and a cost-effectiveness threshold of euro25,000 per QALY were applied.ResultsIn the base case analysis, TIPSS was estimated to be cost-effective as a pre-emptive treatment for indication 1 (incremental cost and QALYs of - euro230 and 0.211, respectively). TIPSS also remained cost-effective (euro16,819/QALY) in a conservative scenario analysis, conducted with an alternate source for clinical parameters. The key drivers of the outcomes were survival for the comparator arm, mean band ligation outpatient procedures, and TIPSS treatment costs. TIPSS was estimated to dominate the comparator for indication 2 (incremental cost and QALYs of - euro25,687 and 0.531, respectively). The key drivers of the outcomes were monthly paracentesis sessions and cost per inpatient stay for those undergoing paracentesis.ConclusionsTIPSS is likely to be a cost-effective and a cost-saving treatment in patients with cirrhosis in indications 1 and 2, compared with standard treatments. The analyses estimate clinical benefits along with reduced healthcare costs from avoided downstream resource consumption.
引用
收藏
页码:3006 / 3020
页数:15
相关论文
共 50 条
  • [1] An Economic Analysis of Transjugular Intrahepatic Portosystemic Covered Stent Shunt for Variceal Bleeding and Refractory Ascites in a Spanish Setting
    Rafael Bañares
    Agustín Albillos
    Mitesh Nakum
    Salvador Gea
    Angel Varghese
    William Green
    Advances in Therapy, 2023, 40 : 3006 - 3020
  • [2] Economic evaluation of covered stents for transjugular intrahepatic portosystemic stent shunt in patients with variceal bleeding and refractory ascites secondary to cirrhosis
    Mattock, Richard
    Tripathi, Dhiraj
    O'Neill, Frank
    Craig, Joyce
    Tanner, Jennifer
    Patch, David
    Aithal, Guruprasad
    BMJ OPEN GASTROENTEROLOGY, 2021, 8 (01):
  • [3] Patient Selection for Transjugular Intrahepatic Portosystemic Stent Shunt (TIPSS) Insertion in Variceal Bleeding and Refractory Ascites
    A. Dhaliwal
    M. J. Armstrong
    D. Tripathi
    Current Hepatology Reports, 2017, 16 (3) : 241 - 249
  • [4] Decision making for transjugular intrahepatic portosystemic stent shunt in refractory ascites and variceal bleeding: MELD, or not MELD, that is the question
    Pitton, Michael B.
    Zimmermann, Tim
    Mildenberger, Philipp
    Weinmann, Arndt
    Kloeckner, Roman
    Dueber, Christoph
    Mittler, Jens
    Hoppe-Lotichius, Maria
    Otto, Gerd
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 (1S) : E214 - E222
  • [5] Decision making for transjugular intrahepatic portosystemic stent shunt in refractory ascites and variceal bleeding: MELD, or not MELD, that is the question
    Pitton, Michael B.
    Zimmermann, Tim
    Mildenberger, Philipp
    Weinmann, Arndt
    Kloeckner, Roman
    Dueber, Christoph
    Mittler, Jens
    Hoppe-Lotichius, Maria
    Otto, Gerd
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 : E214 - E222
  • [6] THE TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC STENT-SHUNT PROCEDURE FOR VARICEAL BLEEDING
    ROSSLE, M
    HAAG, K
    OCHS, A
    SELLINGER, M
    NOLDGE, G
    PERARNAU, JM
    BERGER, E
    BLUM, U
    GABELMANN, A
    HAUENSTEIN, K
    LANGER, M
    GEROK, W
    NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (03): : 165 - 171
  • [7] Transjugular Intrahepatic Portosystemic Shunt: The Covered Stent
    Patel, T.
    Funaki, B.
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2010, 194 (05)
  • [8] THE TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC STENT-SHUNT PROCEDURE FOR REFRACTORY ASCITES
    OCHS, A
    ROSSLE, M
    HAAG, K
    HAUENSTEIN, KH
    DEIBERT, P
    SIEGERSTETTER, V
    HUONKER, M
    LANGER, M
    BLUM, HE
    NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (18): : 1192 - 1197
  • [9] Clinical outcome following transjugular intrahepatic portosystemic shunt (TIPS) for recurrent variceal bleeding and refractory ascites
    Kaufmann, M
    Meyenberger, C
    Schwizer, W
    Pfammatter, T
    Fried, M
    GASTROENTEROLOGY, 1997, 112 (04) : A1298 - A1298
  • [10] TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC STENT SHUNT FOR LIFE-THREATENING VARICEAL BLEEDING
    ENCARNACION, CE
    PALMAZ, JC
    RIVERA, FJ
    LUTZ, JD
    MOSS, JG
    JOSEPH, AE
    RADIOLOGY, 1992, 185 : 259 - 259